Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
We report integrated safety analyses of tofacitinib-treated patients with moderate to severe UC.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: William J. Sandborn, Juli án Panés, Geert R. D’Haens, Bruce E. Sands, Chinyu Su, Michele Moscariello, Thomas Jones, Ron Pedersen, Gary S. Friedman, Nervin Lawendy, Gary Chan Source Type: research
More News: Clinical Trials | Gastroenterology | Inflammatory Bowel Disease | Legislation | Ulcerative Colitis